Zobrazeno 1 - 10
of 16
pro vyhledávání: '"M. V. Avksent'eva"'
Autor:
F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev
Publikováno v:
Фармакоэкономика, Vol 12, Iss 2, Pp 115-124 (2019)
Since generics and biosimilars have entered the Russian market of medications, there are new trends in the general picture of drug prices and consumption. In the present study, we analyze these trends to enable the prediction of possible savings or r
Externí odkaz:
https://doaj.org/article/5ace1e8183464f19a9ff8e6c63fb011a
Publikováno v:
Фармакоэкономика, Vol 10, Iss 4, Pp 53-60 (2018)
According to the current legislation, the standards of medical care lay the ground for the development of a program on state guarantees (SGP) to deliver free medical care to the citizens. While this standard provides an opportunity for calculating th
Externí odkaz:
https://doaj.org/article/6b34ca3e44534cba8e12f5d2c609a887
Autor:
M. V. Avksent'eva
Publikováno v:
Вопросы современной педиатрии, Vol 13, Iss 4, Pp 54-62 (2014)
Diagnostic-related groups (DRG) are being implemented in Russian Federation since 2012 for hospital and day hospital payment. Unification of provider-payment methods and increase of health care efficiency are considered as the main goal of DRG. Prese
Externí odkaz:
https://doaj.org/article/fda6d053f9d8473fae5b019c700d969e
Publikováno v:
Фармакоэкономика, Vol 12, Iss 2, Pp 115-124 (2019)
Since generics and biosimilars have entered the Russian market of medications, there are new trends in the general picture of drug prices and consumption. In the present study, we analyze these trends to enable the prediction of possible savings or r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36a81439f347437e5731e92c285e7e41
https://www.pharmacoeconomics.ru/jour/article/view/292
https://www.pharmacoeconomics.ru/jour/article/view/292
Publikováno v:
Фармакоэкономика, Vol 10, Iss 4, Pp 53-60 (2018)
According to the current legislation, the standards of medical care lay the ground for the development of a program on state guarantees (SGP) to deliver free medical care to the citizens. While this standard provides an opportunity for calculating th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b974c3a85b9d644375fb277e3fb13507
https://doi.org/10.17749/2070-4909.2017.10.4.053-060
https://doi.org/10.17749/2070-4909.2017.10.4.053-060
Publikováno v:
Problemy endokrinologii. 55(1)
Integrated clinical and economic analysis of the efficiency of screening was made in patients with adrenal incidentalomas under the established practical conditions; the average cost of screening of a patient with adrenal incidentalomas and the cost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88882fb2051b9ff8d1db44f4f0f61b84
https://pubmed.ncbi.nlm.nih.gov/31569874
https://pubmed.ncbi.nlm.nih.gov/31569874
Publikováno v:
N.N. Priorov Journal of Traumatology and Orthopedics. 20:46-53
Cost minimization analysis was performed on the basis of the efficacy and safety evaluation of dabigatran etexilate (DE, Pradaxa®) versus other common anticoagulants (AC). Total costs including laboratory and instrumental examinations, consultations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0af8c351c32808164b60351a532b04d1
https://doi.org/10.17816/vto20130246-53
https://doi.org/10.17816/vto20130246-53
Autor:
M V Sura, M V Avksent'eva, V V Omel'yanovskiy, A A Kubanova, M V Avksentiyeva, V V Omeliyanovsky
Publikováno v:
Vestnik dermatologii i venerologii. 87:63-70
There was a clinical and economic study of ustekinumab (stelara) as compared to etanercept (enbrel), infliximab (remicade) and adalimumab (humira) for treating patients with severe psoriasis. The clinical efficacy and safety of the biological drugs w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab18c060d2d8fb4d5bf5c77ce08363d1
https://doi.org/10.25208/vdv1020
https://doi.org/10.25208/vdv1020
Autor:
M V, Avksent'eva, K V, Gerasimova, G R, Khachatrian, M Iu, Frolov, V V, Omel'ianovskiĭ, N A, Avksent'ev
Publikováno v:
Urologiia (Moscow, Russia : 1999). (5)
Overactive bladder syndrome (OAB), accompanied by incontinence, is a relatively common disease. Currently, in the Russian Federation, unfortunately, management of patients with OAB includes the recommendations for symptomatic use of incontinence pads
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::feab848458c71849ac0a243478485d56
https://pubmed.ncbi.nlm.nih.gov/25807761
https://pubmed.ncbi.nlm.nih.gov/25807761
Autor:
M V, Avksent'eva, A V, Chupin
Publikováno v:
Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery. 19(3)
Peripheral arteries occlusive disease (PAOD) is a prevalent illness that needs improved pharmacological management, especially for patients not eligible for surgical revascularization. Prostanoids (alprostadil or iloprost) were shown to be effective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f4a55b0aa9a48e7a8aae41bd76b89854
https://pubmed.ncbi.nlm.nih.gov/24300486
https://pubmed.ncbi.nlm.nih.gov/24300486